Matthew Link insider trades: Sight Sciences (SGHT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | SGHT | ↓ Sell | 4,889 | $4.10 | $20K | Direct | Jul 7, 2025 (5d) |
| Apr 2, 2025 | SGHT | ↓ Sell | 5,042 | $2.31 | $12K | Direct | Apr 3, 2025 (1d) |
| Oct 21, 2024 | SGHT | ↓ Sell | 42,318 | $5.79 | $245K | Direct | Oct 21, 2024 (0d) |
| Oct 17, 2024 | SGHT | ↓ Sell | 41,704 | $5.87 | $245K | Direct | Oct 18, 2024 (1d) |
| Jun 8, 2020 | NUVA | ↓ Sell10b5-1 | 3,000 | $67.00 | $201K | Direct | Jun 10, 2020 (2d) |
| Jan 16, 2020 | NUVA | ↓ Sell10b5-1 | 3,000 | $79.80 | $239K | Direct | Jan 17, 2020 (1d) |
| Dec 24, 2019 | NUVA | ↓ Sell10b5-1 | 3,500 | $77.38 | $271K | Direct | Dec 27, 2019 (3d) |
| May 2, 2019 | NUVA | ↓ Sell10b5-1 | 10,100 | $62.00 | $626K | Direct | May 6, 2019 (4d) |
| Nov 21, 2018 | NUVA | ↓ Sell10b5-1 | 4,889 | $62.22 | $304K | Direct | Nov 26, 2018 (5d) |
| Nov 19, 2018 | NUVA | ↓ Sell10b5-1 | 2,582 | $62.02 | $160K | Direct | Nov 20, 2018 (1d) |
| Dec 12, 2016 | NUVA | ↓ Sell10b5-1 | 10,303 | $67.99 | $701K | Direct | Dec 14, 2016 (2d) |
| Oct 5, 2015 | NUVA | ↓ Sell10b5-1 | 1,714 | $50.72 | $87K | Direct | Oct 5, 2015 (0d) |
| Aug 6, 2015 | NUVA | ↓ Sell10b5-1 | 1,888 | $55.70 | $105K | Direct | Aug 10, 2015 (4d) |
| May 4, 2015 | NUVA | ↓ Sell10b5-1 | 5,460 | $44.30 | $242K | Direct | May 6, 2015 (2d) |
| Mar 3, 2015 | NUVA | ↓ Sell10b5-1 | 7,500 | $44.46 | $333K | Direct | Mar 3, 2015 (0d) |
| Feb 5, 2015 | NUVA | ↓ Sell10b5-1 | 4,078 | $45.77 | $187K | Direct | Feb 5, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGHT insiders
Open-market trades in the last 12 months
About Matthew Link's insider trades
Matthew Link is Chief Commercial Officer at Sight Sciences (SGHT). Since Feb 5, 2015, Matthew has reported no open-market purchases and 16 sales worth $4.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
12 sales (87% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (26 filings), shares withheld for taxes (26 filings), option exercises (14 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGHT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.